150 related articles for article (PubMed ID: 6354151)
1. Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial.
Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Weiner HL
Arch Neurol; 1983 Oct; 40(11):687-90. PubMed ID: 6354151
[No Abstract] [Full Text] [Related]
2. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
Weiner HL; Dau PC; Khatri BO; Petajan J; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav J
Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062
[No Abstract] [Full Text] [Related]
4. Plasmapheresis with immunosuppressive drug therapy in progressive multiple sclerosis. A pilot study.
Khatri BO; Koethe SM; McQuillen MP
Arch Neurol; 1984 Jul; 41(7):734-8. PubMed ID: 6234867
[TBL] [Abstract][Full Text] [Related]
5. Scoring techniques and problems in the evaluation of change in patients.
Slater RJ
Arch Neurol; 1983 Oct; 40(11):675-7. PubMed ID: 6625974
[No Abstract] [Full Text] [Related]
6. [Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years].
Trouillas P; Neuschwander P; Nighoghossian N; Adeleine P; Tremisi P
Rev Neurol (Paris); 1989; 145(5):369-77. PubMed ID: 2662340
[TBL] [Abstract][Full Text] [Related]
7. Plasmapheresis in chronic progressive multiple sclerosis: pro.
McQuillen MP
J Clin Apher; 1991; 6(4):207-10. PubMed ID: 1816242
[No Abstract] [Full Text] [Related]
8. Experimental therapies for multiple sclerosis: current status.
Goodkin DE; Ransohoff RM; Rudick RA
Cleve Clin J Med; 1992; 59(1):63-74. PubMed ID: 1372538
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic trials in multiple sclerosis.
Noseworthy JH; Seland TP; Ebers GC
Can J Neurol Sci; 1984 Aug; 11(3):355-62. PubMed ID: 6205737
[No Abstract] [Full Text] [Related]
10. Experience with cyclophosphamide in multiple sclerosis: the cons.
Likosky WH
Neurology; 1988 Jul; 38(7 Suppl 2):14-8. PubMed ID: 3290708
[TBL] [Abstract][Full Text] [Related]
11. Effect of lymphocytapheresis plus cyclophosphamide on the course of a chronic progressive form of multiple sclerosis.
Ferla S; Meneghetti G; Spartà S; Belloni M; Ongaro G
Ital J Neurol Sci; 1985 Sep; 6(3):283-6. PubMed ID: 4066266
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive drug therapy with plasmapheresis in chronic progressive multiple sclerosis: a controlled study.
Khatri BO; Harrington GJ; Schmoll D; McQuillen MP
J Clin Apher; 1984; 2(1):135-7. PubMed ID: 6536654
[No Abstract] [Full Text] [Related]
13. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs.
Khatri BO; McQuillen MP; Harrington GJ; Schmoll D; Hoffmann RG
Neurology; 1985 Mar; 35(3):312-9. PubMed ID: 3974889
[TBL] [Abstract][Full Text] [Related]
14. Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
Likosky WH; Fireman B; Elmore R; Eno G; Gale K; Goode GB; Ikeda K; Laster J; Mosher C; Rozance J
J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1055-60. PubMed ID: 1783915
[TBL] [Abstract][Full Text] [Related]
15. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
16. A closer look at plasmapheresis in multiple sclerosis: the cons.
Tindall R
Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
[TBL] [Abstract][Full Text] [Related]
17. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis].
Hommes OR
Ned Tijdschr Geneeskd; 1978 Oct; 122(41):1545-51. PubMed ID: 358004
[No Abstract] [Full Text] [Related]
18. Plasma exchange in acute multiple sclerosis. Design of a cooperative study.
Weiner HL; Dau P; Birnbaum G; Feldstein M; Khatri B; Petajan J; McQuillen MP
Arch Neurol; 1983 Oct; 40(11):691-2. PubMed ID: 6354152
[No Abstract] [Full Text] [Related]
19. The use of cyclophosphamide in the treatment of multiple sclerosis.
Weiner HL; Hauser SL; Hafler DA; Fallis RJ; Lehrich JR; Dawson DM
Ann N Y Acad Sci; 1984; 436():373-81. PubMed ID: 6099707
[No Abstract] [Full Text] [Related]
20. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Propper RD; Mills JA; Weiner HL
N Engl J Med; 1983 Jan; 308(4):173-80. PubMed ID: 6294517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
